ArticleAnnals of the rheumatic diseases2022

Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis.

Marc Corbera-Bellalta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.